Immature function of the alveolar macrophage increases the risk of pulmonary infections in premature newborns. In utero alcohol increases fetal systemic oxidative stress. Because the premature lung is deficient in glutathione (GSH), we hypothesized that chronic in utero alcohol (ethanol) exposure exacerbates the oxidative stress within the developing lung, thereby impairing alveolar macrophage function. Additionally, we evaluated the effects of in vivo and in vitro GSH availability on ethanol-exposed macrophage function. Using a guinea pig model of chronic in utero ethanol exposure, fetal epithelial lining fluid (ELF) and alveolar macrophage GSH were decreased with increased markers of oxidative stress. Ethanol-exposed macrophage exhibited impaired phagocytosis and increased apoptosis compared with gestational control. When the GSH precursor S-adenosyl-methionine (SAM) was added to the maternal drinking water containing ethanol, fetal ELF and macrophage GSH were maintained and ELF oxidative stress diminished. In vivo maternal SAM therapy maintained macrophage phagocytosis and decreased apoptosis. In vitro GSH supplements also improved phagocytosis and viability in both premature and ethanolexposed macrophage. This suggested that in utero ethanol impaired premature macrophage function and viability via decreased GSH availability. Furthermore, GSH supplementation during and after ethanol exposure improved fetal macrophage function and viability. These results add a new dimension to the detrimental effects of fetal alcohol exposure on the developing alveolar macrophage, raising the possibility of GSH therapy to augment premature alveolar macrophage function. Fetal alcohol exposure remains a significant problem in our society. Alcohol abuse and binge drinking by pregnant women has been estimated at an alarming 35% of pregnancies (1-3). Fetal alcohol syndrome or alcohol-related neurodevelopmental disorder has been estimated to occur in ‫0001/1ف‬ pregnancies (4). Because there is a strong relationship between cocaine abuse and concurrent alcohol ingestion (5-7), and both substances may increase the risk of premature delivery (7, 8) , a significant population of premature infants is exposed to alcohol in utero.
Fetal alcohol exposure remains a significant problem in our society. Alcohol abuse and binge drinking by pregnant women has been estimated at an alarming 35% of pregnancies (1-3). Fetal alcohol syndrome or alcohol-related neurodevelopmental disorder has been estimated to occur in ‫0001/1ف‬ pregnancies (4) . Because there is a strong relationship between cocaine abuse and concurrent alcohol ingestion (5-7), and both substances may increase the risk of premature delivery (7, 8) , a significant population of premature infants is exposed to alcohol in utero.
In animal models of fetal alcohol exposure, alcohol increases systemic oxidative stress in the developing fetus (9 -14) . A decrease in the antioxidant GSH has been demonstrated, particularly in the alcohol-exposed fetal liver (9, 15, 16) . As an essential antioxidant in the body, GSH is normally present in high concentrations in the ELF of the lung (17) . The fetal lung is at risk for increased oxidative stress during development, because maturation of antioxidant systems, including GSH, is gestationally dependent (18, 19) . A reduction in alveolar GSH, as seen in the premature infant, leaves the preterm lung susceptible to increased pulmonary oxidative injury (20, 21) and chronic lung disease (18, 22) . The impact of the oxidative stress of fetal alcohol exposure superimposed on the low GSH environment of the developing lung has received little attention.
The immature alveolar macrophage's functions contribute to an increased risk of infections in the premature lung. When compared with the adult, the newborn macrophage functions of chemotaxis, phagocytosis, and bacterial killing are diminished (23) (24) (25) . GSH is essential for optimal functioning of phagocytic cells, such as the alveolar macrophage. For neutrophils, phagocytosis is impaired in many clinical states associated with decreased GSH (26) , and the essential role for GSH is supported by the ability of in vitro GSH to normalize intracel-ELF oxidative stress. To further evaluate the ELF for signs of oxidative stress, we measured the lipid peroxidation product HNE via commercially available ELISA (Research Diagnostics, Flanders, NJ). Values for HNE were normalized to ELF IgA, a secretory product not altered by injury (34 -36) . The ELF IgA was measured by ELISA with the primary antibody obtained from Sigma Chemical Co.
Phagocytosis. After isolation, macrophage were plated at 10 6 cell/mL in DMEM-F-12 media with 2% fetal bovine serum, penicillin plus streptomycin and cultured at 37°C, 5% CO 2 . Supplemental GSH (200 M) was added when appropriate to the culture media. After 2 h, alveolar macrophages were washed, FITC-labeled inactivated Staphylococcus aureus (Molecular Probes, Eugene, OR) was added in a 1:1 ratio (alveolar macrophage:bacteria), and the cells were cultured for an additional 2 h (37). After the incubation period, cells were washed and phagocytosis of S. aureus was determined via quantitative digital analysis of fluorescence (QImaging, Burnaby, BC, Canada) with data analysis via Image-Pro Plus for Windows. Values are presented as mean relative fluorescent units (RFU)/cell Ϯ SEM and the mean percentage of cells fluorescently positive Ϯ SEM as tallied from at least 10 experimental fields per set.
Apoptosis. After culture for 4 h, macrophages were fixed with 3.7% paraformaldehyde and nonspecific binding blocked with BSA. Apoptosis was determined by staining for the cleaved PARP, and for DNA fragmentation via terminal dUTP nick-end labeling (TUNEL). The primary antibody for cleaved PARP (Oncogene, Cambridge, MA) was added in a 1:100 dilution and the sample incubated for 2 h. Cells were serially rinsed with PBS and the secondary antibody Statistical analysis. SigmaStat for Windows (Systat Software, Inc., Point Richmond, CA) was used for statistical calculations. ANOVA was used to detect overall differences. Statistical differences between groups were detected by posthoc analysis (Student-Newman-Keuls) and a p Յ 0.05 was considered significant.
RESULTS
In utero ethanol exposure decreased ELF GSH availability. Fetal ELF GSH was significantly decreased after in utero ethanol exposure (p Ͻ 0.05, Fig. 1A) , with a corresponding increase in the oxidized portion of GSSG when compared with gestational controls (p Ͻ 0.05, Fig. 1B ). Therefore, in utero ethanol increased the oxidative stress of the fetal airway as indicated by decreased GSH and increased GSSG/(GSSG ϩ GSH). The addition of the GSH precursor SAM to the maternal diet during ethanol ingestion maintained fetal ELF GSH and decreased oxidized GSSG (p Ͻ 0.05 versus ethanol, Fig. 1 , A and B, respectively).
In utero ethanol increased products of oxidative stress in the ELF. The lipid peroxidation product HNE was significantly increased in the fetal ELF after in utero ethanol expo-77 sure (p Ͻ 0.05 versus control, Fig. 2 ). When dams were given ethanol ϩ SAM, the expected increase in free HNE in the fetal ELF due to in utero ethanol exposure was significantly attenuated (p Ͻ 0.05 versus ethanol, Fig. 2 ).
Decreased ELF GSH corresponded with altered alveolar macrophage GSH. Because in utero ethanol exposure decreased GSH availability and increased oxidative stress in the fetal ELF, we investigated whether this was accompanied by decreased GSH within the fetal alveolar macrophage. Fetal alveolar macrophage were isolated and GSH and GSSG measured via HPLC (33) . In utero ethanol exposure decreased the fetal macrophage GSH/GSSG ratio by ‫%37ف‬ (p Ͻ 0.05 versus control, Fig. 3 ). The addition of SAM to the maternal diet during ethanol ingestion maintained macrophage GSH/GSSG at control levels (p Ͻ 0.05 versus ethanol, Fig. 3 ).
In utero ethanol increased lipid peroxidation in the alveolar macrophage. To further verify that in utero ethanol exposure increased oxidative stress in the fetal alveolar macrophage, the cells were evaluated for the presence of HNE and MDA, lipid peroxidation by-products. In utero ethanol exposure increased MDA staining on the macrophage by Ͼ150% (p Ͻ 0.05 versus control, Fig. 4A ), whereas HNE staining was increased by Ͼ80% (p Ͻ 0.05 versus control, Fig. 4B ). Concurrent treatment with the glutathione precursor SAM during the ethanol ingestion normalized both MDA staining per cell and HNE staining per cell to control levels (p Ͻ 0.05 versus ethanol, Fig. 4, A and B, respectively) .
Fetal ethanol exposure impaired premature macrophage phagocytosis. When compared with the macrophages from pair-fed gestational controls, the mean phagocytosis per cell was decreased by ‫%03ف‬ after in utero ethanol exposure (p Ͻ 0.05 versus control, Fig. 5A ). Ethanol exposure also reduced the percentage of cells positive for ingested S. aureus by In utero ethanol exposure decreased fetal alveolar macrophage survival. Because of the decreased GSH availability for the ethanol-exposed macrophage and the dramatic reduction in cell phagocytosis, we postulated that the dysfunction of the ethanol-exposed macrophage was due to increased apoptotic cell death. To determine apoptosis, cells were stained after 4 h culture for the cleavage of PARP by caspase-3, an early indicator of the apoptosis pathway (38) , and for DNA fragmentation via the TUNEL assay. Fetal ethanol exposure significantly increased the percentage of cells staining positive for PARP by more than 2-fold (p Ͻ 0.05 versus control, Fig. 6A ). Similarly, TUNEL-positive cells were significantly increased in the ethanol group compared with control (p Ͻ 0.05 versus control, Fig. 6B ). The addition of SAM normalized the percentage of cells with any staining for PARP to control values and significantly diminished TUNEL staining (p Ͻ 0.05 versus ethanol, respectively, Fig. 6, A and B) . These results suggested that GSH availability in the ELF protected the fetal macrophage from ethanol-induced apoptosis.
In vitro GSH attenuated macrophage oxidative stress and improved function and viability. Given the role of extracellular GSH availability in macrophage oxidative stress, function, and viability, the possibility of macrophage rescue by in vitro GSH supplements was addressed. After isolation, supplemental GSH (200 M) was added to the culture media and macrophage oxidative stress, as determined by HNE and MDA staining, phagocytosis, and apoptosis were evaluated. In vitro GSH supplementation significantly diminished MDA per cell in the ethanol-exposed macrophage (p Ͻ 0.05 compared with ethanol without GSH, Fig. 7A ). Similarly, HNE staining was significantly attenuated by in vitro GSH supplementation in the ethanol macrophage (p Ͻ 0.05 compared with ethanol without GSH, Fig. 7B) .
Furthermore, the addition of GSH in vitro improved the mean phagocytosis per cell (Fig. 8A ) and the percentage phagocytosis (Fig. 8B ) in both the premature control macrophages and the ethanol-exposed macrophages (p Ͻ 0.05 compared with control without GSH, p Ͻ 0.05 compared with ethanol without GSH, Fig. 8, A and B) . 
DISCUSSION
A growing body of clinical and experimental evidence has demonstrated that the chronic oxidative stress of alcohol exposure decreases the availability of the antioxidant GSH in the adult lung (39) and independently increases the risk and severity of acute respiratory distress syndrome (40) . Indeed, experimental studies from our laboratories investigating the adult 
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"alcoholic lung" have demonstrated that GSH homeostasis is impaired, with decreased GSH and increased oxidized GSSG in the ELF (41, 42) . This state of chronic oxidative stress results in increased acute lung injury with sepsis, impaired type II epithelial cell function (42) , and increased sensitivity to oxidant-induced apoptosis (33) .
Prematurity is associated with decreased GSH availability in the ELF and decreased alveolar macrophage phagocytosis (22, 23) . The current study shows that, similar to the adult, the fetus exposed to ethanol in utero demonstrated decreased GSH availability in the ELF compared with the pair-fed control. This was accompanied by increased oxidant stress in the ELF as assessed by diminished GSH/GSSG and increased lipid peroxidation. This ethanol-induced chronic oxidative stress in the ELF was coupled with oxidative stress in the alveolar macrophages as assessed by decreased GSH/GSSG and increased lipid peroxidation (MDA and HNE). Such chronic oxidative stress had physiologic ramifications for the alveolar macrophage, including decreased function such as phagocytosis and diminished cellular viability, when compared with cells from gestationally matched pair-fed control pups.
The increased macrophage apoptosis demonstrated after chronic in utero ethanol parallels the oxidant-induced injury and apoptosis described in other organs models of fetal alcohol syndrome, such as the developing brain (13) and liver (43) . Because the entire fetus is exposed to the oxidative stress of in utero ethanol exposure, our current results suggest that the developing resident alveolar macrophage within the lung is similarly vulnerable to the toxicity of in utero ethanol. Antioxidant replacement has been described as beneficial to other cell systems exposed to the chronic oxidative stress of fetal alcohol exposure. Replacement of GSH or vitamin E in the developing ethanol-exposed fetus has restored fetal growth (44) , blunted neurologic injury (45) , and preserved hepatic cell function (46, 47) . In the current study, maintaining GSH availability in vivo via the maternal GSH donor SAM during ethanol ingestion protected the fetal lung and alveolar macrophage from oxidative stress. This was evident by attenuation of lipid peroxidation, as well as increased GSH/GSSG in the both the ELF and the alveolar macrophages. Maintenance of GSH status corresponded with protection of the developing macrophage from ethanol-induced dysfunction, with increased phagocytosis and decreased apoptosis. These results suggested that ethanol-induced decreases in GSH availability to the fetal lung were a central feature in the ethanol toxicity to the alveolar macrophages. Furthermore, increasing GSH availability in vitro improved control pair-fed fetal macrophage phagocytosis and blunted ethanol-induced dysfunction, in part by reducing apoptosis in the cell.
We chose to examine macrophage function at one point in gestation after chronic ethanol exposure. At this point ‫03ف(‬ wk of human gestation), GSH remains deficient in the developing fetus, as levels normally increase with gestation, with a surge at the time of term delivery (18) . In our guinea pig model, the pair-fed control premature macrophage demonstrated cellular vulnerability, as evidenced by the presence of oxidative stress and apoptosis. Pair-feeding and diminished maternal food intake in the control dams may have contributed to the cellular vulnerability seen in the control premature macrophage. The additional oxidative stress of ethanol exposure augmented this vulnerability. Premature newborns are often exposed to increased oxidative stress in the lung due to the need for oxygen and/or ventilator therapy. Additional studies are necessary to evaluate whether the detrimental effects of ethanol-induced oxidative stress on the developing alveolar macrophage persist throughout gestation, especially at term when the GSH system approaches maturation.
In summary, this study demonstrates a novel deleterious effect of fetal ethanol exposure on the function and viability of the developing alveolar macrophage. In utero ethanol impaired macrophage function in part via decreased GSH availability in the lung. Maternal GSH supplementation during ethanol exposure and in vitro GSH supplementation after ethanol exposure protected the developing macrophage from apoptosis and dysfunction. The clinical implications and significance of these findings for the premature newborn's risk of infection and infectious complications remain under investigation. We hypothesize that the need for GSH availability in alveolar macrophage functioning can be applicable to other conditions in pregnancy that increase oxidative stress for the developing fetus. These include diabetes (48, 49) , maternal smoking (50), pregnancy-induced hypertension (50 -52), intrauterine growth retardation (53) , and preterm premature rupture of membranes (54) . Therefore, the potential implica- 
80
tions of these results have a broader therapeutic potential than maternal alcohol abuse alone. Moreover, this study provides important evidence for the need to identify the alcohol-exposed premature newborn. Future studies are necessary to explore a potential role of GSH availability to augment macrophage function in premature newborns under exaggerated oxidative stress, such as those exposed to alcohol in utero.
